0000937556-17-000065.txt : 20170404 0000937556-17-000065.hdr.sgml : 20170404 20170404171802 ACCESSION NUMBER: 0000937556-17-000065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170331 FILED AS OF DATE: 20170404 DATE AS OF CHANGE: 20170404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MASIMO CORP CENTRAL INDEX KEY: 0000937556 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 330368882 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 52 DISCOVERY CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-297-7000 MAIL ADDRESS: STREET 1: 52 DISCOVERY CITY: IRVINE STATE: CA ZIP: 92618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: de Raad Mark CENTRAL INDEX KEY: 0001363597 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33642 FILM NUMBER: 17739644 MAIL ADDRESS: STREET 1: 40 PARKER CITY: IRVINE STATE: CA ZIP: 92618 4 1 wf-form4_149134066727654.xml FORM 4 X0306 4 2017-03-31 0 0000937556 MASIMO CORP MASI 0001363597 de Raad Mark C/O MASIMO CORPORATION 52 DISCOVERY IRVINE CA 92618 0 1 0 0 EVP & Chief Financial Officer Common Stock 2017-03-31 4 M 0 6000 37.84 A 14660 D Common Stock 2017-03-31 4 S 0 6000 93.1323 D 8660 D Common Stock 2017-03-31 4 M 0 12000 31.01 A 20660 D Common Stock 2017-03-31 4 S 0 12000 93.135 D 8660 D Common Stock 2017-04-03 4 M 0 12000 21.97 A 20660 D Common Stock 2017-04-03 4 S 0 12000 93.3121 D 8660 D Common Stock 2017-04-04 4 M 0 18000 28.03 A 26660 D Common Stock 2017-04-04 4 S 0 18000 93.3354 D 8660 D Non-Qualified Stock Option (Right to Buy) 37.84 2017-03-31 4 M 0 6000 37.84 D 2017-02-28 2026-02-28 Common Stock 6000.0 24000 D Non-Qualified Stock Option (Right to Buy) 31.01 2017-03-31 4 M 0 12000 31.01 D 2016-03-20 2025-03-20 Common Stock 12000.0 18000 D Non-Qualified Stock Option (Right to Buy) 21.97 2017-04-03 4 M 0 12000 21.97 D 2014-05-28 2023-05-28 Common Stock 12000.0 12000 D Non-Qualified Stock Option (Right to Buy) 28.03 2017-04-04 4 M 0 18000 28.03 D 2015-02-18 2024-02-18 Common Stock 18000.0 12000 D The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of March 17, 2017, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.77 per share to a high of $93.48 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.76 per share to a high of $93.50 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.76 per share to a high of $94.67 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.94 per share to a high of $93.83 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This option was granted on February 29, 2016 and is exercisable as the option vests. The option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. This option was granted on March 20, 2015 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. This option was granted on May 28, 2013 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. This option was granted on February 18, 2014 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. /s/ David J. Van Ramshorst, Attorney-In-Fact 2017-04-04